Breast cancer treatment in Ireland is poised for a transformative change starting June 1st, with the Health Service Executive ...

A leading breast cancer specialist has called for ring-fenced funding for more innovative procedures for breast cancer after 12,000 Irish women avoided chemotherapy thanks to a new test.

The Health Service Executive (HSE) has approved a new treatment option for people with breast cancer at high-risk of ...

THE HSE has approved a new drug for people with breast cancer that can reduce the chances of recurrence by up to 30 per cent.

A breakthrough treatment option to cut the risk of breast cancer returning has been approved by the HSE. The Irish Cancer ...

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits ...

Patient advocates and oncologists have welcomed a HSE decision to reimburse a new treatment option for breast cancer that is ...

The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer. This significantly reduces ...

Sharon Greeves greeted confirmation that the HSE had approved the new breast cancer treatment drug abemaciclib as "the best ...

The approval by the HSE of a new treatment option for people with breast cancer at high-risk of recurrence, which could ...

POETIC-A is investigating whether adding the drug abemaciclib alongside hormone therapy can help prevent higher risk early breast cancer from returning. Abemaciclib works by blocking molecules which ...

He has previously received funding from the CASS Foundation. The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme ...